Publicly available resource monitors the development of therapies to treat and prevent disease
WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development of treatments and vaccines for COVID-19.
The tracker is available online at https://milkeninstitute.org/covid-19-tracker. It is developed and maintained by FasterCures, a center of the Milken Institute, with an Advisory Council comprised of a Nobel Laureate researcher, former FDA chiefs, and industry leaders.
“We seek to accelerate efforts to find new treatments or vaccines, amplify what’s working, hold the system and its players accountable, and expand the global discussion about how to create durable, long term solutions,” says Esther Krofah, executive director of FasterCures. “COVID-19 is putting that approach to the test. We hope to be a resource promoting effective approaches and strategies."
The Milken Institute COVID-19 vaccine development and treatment tracker is compiled from publicly available sources and will be updated regularly. It will grow to include FDA-approved indications where applicable, as well as basic information about the focus of each clinical trial.
The Milken Institute welcomes input on new treatments and vaccines in development. Please email [email protected] with tips.
Related Content
-
Milken Institute Global Conference Opens October 12
The livestreamed eight-day event features nearly 500 speakers, including top business leaders, health and government officials, activists, entertainers, influencers and more. Los Angeles – October 11, 2020 – The 23rd annual Milken Institute...Read Article -
Are Community Health Workers Saving Lives? A Longitudinal Analysis of State-Level Variation in Community Health Workforce
U.S. health care costs are increasing rapidly while health care outcomes and access vary significantly across the country. Community health workers (CHWs) serve as bridges between the health care system and underserved communities...Read Report11 11Ross Devol and Marlon Graf -
Rx for Innovation: Recommendations for the New Administration
FasterCures wants President-elect Donald Trump to be ready to address biomedical innovation on day one. Biomedical innovation is vital to America's health and economic well-being. However, these benefits, and U.S. leadership in the life...Read Report -
Advancing Tech-Enabled Health and Home Care
Over the last two-plus years, the Milken Institute Center for the Future of Aging has explored the financial and care-delivery gaps in the long-term care market, specifically the barriers to affordable care for middle-income households and...Read Report11
Lauren Dunning and Caroline Servat -
Shaping Environments to Shape Us: The Case for Longevity Cities
This report presents the case for Longevity Cities to tackle the challenges of global population aging.Read Report11 11 11Upali Nanda, PhD, Harris Eyre, MD, PhD, and Rajiv Ahuja -
The Reinvention of Prevention: How to Fund and Finance a Pivot to a Prevention-First Healthcare System
As part of the debut of the Milken Institute’s Project Prevent initiative in 2024, the Institute conducted a series of interviews with 35 key stakeholders and experts in health, finance, philanthropy, pensions, and public policy to explore...Read Report -
Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Submitted electronically The Honorable Diana DeGette US House of Representatives Washington, DC 20515 The Honorable Fred Upton US House of Representatives Washington, DC 20515 Dear Representatives DeGette and Upton, FasterCures is pleased...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Everything You Ever Wanted To Know About Venture Philanthropy Transactions But Were Afraid To Ask
Since 1989, Schaner & Lubitz, PLLC has closed many transactions for disease foundation clients in the field that has come to be known as Venture Philanthropy. Though each charity and transaction have unique aspects, there are some issues...Read Report -
Building Workforce Capacity to Improve Detection and Diagnosis of Dementia
The Alliance to Improve Dementia Care, part of the Milken Institute’s Center for the Future of Aging, utilizes a multi-sector approach to develop recommendations to improve care for individuals living with dementia across all stages...Read Report11Mac McDermott and Diane Ty -
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that has challenged patients, their families, and the medical community for generations. Although ALS is considered rare, its impact on...Read Report11
-
Implementing Nigeria’s National Strategic Cancer Control Plan and Cancer Research Agenda
Cancer incidence in Nigeria is growing, and mortality rates are high. This report summarizes the roundtable themes and insights, key takeaways, and actionable recommendations.Read Report -
World Leaders Heading to California for Milken Institute Global Conference: April 29-May 2
LOS ANGELES—More than 4,000 international leaders in business, government, science, philanthropy, academia, arts, and culture will meet in California for the 21 st Milken Institute Global Conference beginning April 29, 2018. Confirmed...Read Article